Nuvation Bio NUVB
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$624.3K (14 inflow days, 6 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 51.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 15.16% to 17.66% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Putnam LLC | Mutual Fund | 2026/Q3 | +1,603,403 | 0.5% |
| BNP Paribas Financial Markets SNC | Private Company | 2026/Q3 | +1,494,179 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +1,293,607 | 8.2% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +863,626 | 0.3% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +828,608 | 0.3% |
| Connor, Clark & Lunn Investment Management Ltd. | Mutual Fund | 2026/Q3 | +780,088 | 0.7% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +735,322 | 0.2% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +714,819 | 0.3% |
| Essex Investment Management Company, LLC | Mutual Fund | 2026/Q3 | +673,830 | 0.4% |
| Morgan Stanley | Public Company | 2026/Q3 | +620,073 | 0.6% |
| ACT Capital Management | Hedge Fund | 2026/Q3 | +579,500 | 0.3% |
| Mizuho Financial Group, Inc. | Public Company | 2026/Q3 | +503,376 | 0.1% |
| Barclays PLC | Public Company | 2026/Q3 | +438,904 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +438,189 | 14.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +2,530,463 | 7.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 18 Aug 2026 | Gary Hattersley | Chief Scientific Officer | Derivative Exercise and Sale | -100,000 | $7.09 | – |
| 14 Jul 2026 | Philippe Sauvage | CFO & Principal Financial Officer | Derivative Exercise and Retained | +40,000 | $2.17 | 54,131 |
| 22 Jun 2026 | Kerry Wentworth | Chief Regulatory Officer | Derivative Exercise and Sale | -63,000 | $6.02 | 53,000 |
| 22 Jun 2026 | Stacy Markel | Chief Human Resources Officer | Derivative Exercise and Sale | -125,000 | $6.03 | 32,591 |
| 22 Jun 2026 | Philippe Sauvage | CFO & Principal Financial Officer | Derivative Exercise and Sale | -47,668 | $6.01 | 12,673 |
| 22 Jun 2026 | Moses Makunje | VP of Finance and Principal Accounting & Financial Officer | Intent to Sell (Form 144) | -47,668 | $5.76 | – |
| 8 Jun 2026 | Robert Mashal | Independent Director | Open Market Acquisition | +25,000 | $4.73 | 225,000 |
| 20 May 2026 | Kathryn Falberg | Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 20 May 2026 | Kim Blickenstaff | Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 20 May 2026 | Robert Bazemore | Lead Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 20 May 2026 | Robert Mashal | Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 20 May 2026 | William Vernon | Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 20 May 2026 | Xiangmin Cui | Independent Director | Other Derivative Acquisition | +123,397 | $4.79 | 123,397 |
| 16 Apr 2026 | Kerry Wentworth | Chief Regulatory Officer | Derivative Exercise and Sale | -36,750 | $5.01 | 53,000 |
| 16 Apr 2026 | Dongfang Liu | Derivative Exercise and Sale | -50,000 | $5.02 | 18,000 | |
| 5 Apr 2026 | Kerry Wentworth | Chief Regulatory Officer | Derivative Exercise and Sale | -200,000 | $4.52 | 53,000 |
| 26 Feb 2026 | David Hung | Chairperson & CEO | Other Derivative Acquisition | +1,995,012 | $5.91 | 1,995,012 |
| 26 Feb 2026 | Kerry Wentworth | Chief Regulatory Officer | Other Derivative Acquisition | +748,130 | $5.91 | 748,130 |
| 26 Feb 2026 | Xiangmin Cui | Independent Director | Other Derivative Acquisition | +76,923 | $5.91 | 76,923 |
| 26 Feb 2026 | Stacy Markel | Chief Human Resources Officer | Other Derivative Acquisition | +748,130 | $5.91 | 748,130 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 61,999,741 | 17.7% | 12.5 |
| 15 Oct 2026 | 63,220,203 | 18.0% | 9.7 |
| 30 Sep 2026 | 58,862,812 | 16.8% | 13.9 |
| 15 Sep 2026 | 58,173,586 | 16.6% | 10.9 |
| 31 Aug 2026 | 54,264,998 | 15.5% | 10.7 |
| 14 Aug 2026 | 53,222,212 | 15.2% | 8.9 |
No comments yet — be the first to weigh in on NUVB.
Sign in to join the discussion.